•Potential for Therapeutic Targeting: The findings offer a new avenue for therapeutic strategies, suggesting that targeting the TINAGL1-SMAD4 axis could mitigate the fibrotic complications in Crohn's Disease. Here, SMAD4 is linked to Crohn disease.